Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is cancer biology different in older patients?
Yannick Van Herck, Annelies Feyaerts, Shabbir M.H. Alibhai, et al.
The Lancet Healthy Longevity (2021) Vol. 2, Iss. 10, pp. e663-e677
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Age-associated differences in the cancer molecular landscape
Kasit Chatsirisupachai, Cyril Lagger, João Pedro de Magalhães
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 962-971
Open Access | Times Cited: 41
Screening for Coronary Artery Disease in Cancer Survivors
R. Velusamy, Mark Nolan, Andrew Murphy, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 1, pp. 22-38
Open Access | Times Cited: 37
Global burden of 34 cancers among women in 2020 and projections to 2040: Population‐based data from 185 countries/territories
Habtamu Mellie Bizuayehu, Abel Fekadu Dadi, Kalkidan Hassen Abate, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 8, pp. 1377-1393
Open Access | Times Cited: 23
Educational interventions to reduce depression and anxiety in older adults with cancer in the community: a systematic review, meta-analysis and meta-regression of randomised controlled trials
Chen Ee Low, Renish M Pillay, Finn Jing Jie Teo, et al.
Age and Ageing (2024) Vol. 53, Iss. 6
Closed Access | Times Cited: 12
Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes
Amin Ullah, Yongxiu Chen, Rajeev K. Singla, et al.
Pharmacological Research (2024) Vol. 204, pp. 107213-107213
Open Access | Times Cited: 11
Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review
Nina Rosa Neuendorff, Abdullah Khan, Fabian Ullrich, et al.
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 3, pp. 101734-101734
Open Access | Times Cited: 9
Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non–Small Cell Lung Cancer and Colorectal Cancer
Thomas J. Roberts, Kenneth L. Kehl, Gabriel A. Brooks, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e2310809-e2310809
Open Access | Times Cited: 18
Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics
Yifan Wang, Weiye Deng, DaeYong Lee, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 2, pp. 255-263
Closed Access | Times Cited: 18
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D. Pederson, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 19, pp. 2295-2305
Closed Access | Times Cited: 7
Cutaneous melanoma in older patients
Alessandra Buja, Massimo Rugge, Chiara Trevisiol, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Aging represses lung tumorigenesis and alters tumor suppression
Emily G. Shuldiner, Saswati Karmakar, Min K. Tsai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates
Habtamu Mellie Bizuayehu, Abel Fekadu Dadi, Kedir Y. Ahmed, et al.
Cancer (2024)
Open Access | Times Cited: 6
Inflammation and aging-related disease: A transdisciplinary inflammaging framework
Brian J. Andonian, Joseph A. Hippensteel, Katrina Abuabara, et al.
GeroScience (2024)
Closed Access | Times Cited: 6
The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review
Domenica Disalvo, Erin Moth, Wee Kheng Soo, et al.
Journal of Geriatric Oncology (2023) Vol. 14, Iss. 8, pp. 101585-101585
Closed Access | Times Cited: 15
Relationship between nurses’ psychological capital and satisfaction of elderly cancer patients during the COVID-19 pandemic
Hui He, Na Zhu, Bei Lyu, et al.
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 14
Nutritional Status and Information Provided to Polish Cancer Patients Assessed Using the EORTC QLQ-INFO25 Questionnaire
Elwira Gliwska, Dominika Głąbska, Zuzanna Zaczek, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 697-697
Open Access
Clinical practice guideline: Comprehensive geriatric assessment in the hospital
Barbara Kumlehn, Simone Brefka, Thomas D. Kocar, et al.
Deutsches Ärzteblatt international (2025)
Closed Access
Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study
Inés González‐Barrallo, V.E. Castellón Rubio, J. Sáenz Medina, et al.
Melanoma Research (2025)
Closed Access
Profiles and disparities of the global cancer and subtypes burden among adults aged 65 years and older: changing patterns in incidence and mortality, 1990–2021
He Li, Qianru Li, Yuanjie Zheng, et al.
Science Bulletin (2025)
Closed Access
Antibody-Drug conjugates In elderly patients With Breast Cancer
Marta Bonotto, G Pieri, Rocco Esposto, et al.
The Breast (2025) Vol. 80, pp. 104428-104428
Open Access
Gut microbiota in melanoma: effects and pathogeneses
Wenwen Liu, Xin Yang, Yuwei Zhou, et al.
Microbiological Research (2025), pp. 128144-128144
Closed Access
Development and validation of a postoperative prognostic model for hormone receptor positive early stage breast cancer recurrence
Ruijun Pan, Haoting Shi, Yiqing Shen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Melanoma in Special Populations
Aikaterini Dedeilia, Tobias Braun, Genevieve M. Boland
Surgical Clinics of North America (2025)
Closed Access
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging
Julia Han Noll, Bruce L. Levine, Carl H. June, et al.
Seminars in Immunology (2023) Vol. 70, pp. 101840-101840
Open Access | Times Cited: 12
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression
Hans Wildiers, Thomas Meyskens, Sandrine Marréaud, et al.
The Breast (2022) Vol. 64, pp. 100-111
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top